These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2191437)

  • 1. Detection, prevention, and treatment of retroviral infections.
    Wells KH; Byrne BC; Poiesz BJ
    Semin Oncol; 1990 Jun; 17(3):295-320. PubMed ID: 2191437
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency viruses.
    Weiss RA
    Baillieres Clin Haematol; 1990 Jan; 3(1):207-13. PubMed ID: 2182140
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV/AIDS. Prevention cocktails: combining tools to Stop HIV's spread.
    Cohen J
    Science; 2005 Aug; 309(5737):1002-5. PubMed ID: 16099959
    [No Abstract]   [Full Text] [Related]  

  • 4. Fighting HIV with HIV.
    Secasan IS; Pop DI
    Med Hypotheses; 1998 Jan; 50(1):39-42. PubMed ID: 9488180
    [No Abstract]   [Full Text] [Related]  

  • 5. The brightening future of HIV therapeutics.
    Greene WC
    Nat Immunol; 2004 Sep; 5(9):867-71. PubMed ID: 15334078
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral phenotype and genotype as markers in clinical trials.
    Katzenstein DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S25-34. PubMed ID: 7552510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [First infection by HIV, optimizing the messages of prevention].
    Vayssette P
    Soins; 2009 Dec; (741):10. PubMed ID: 20069733
    [No Abstract]   [Full Text] [Related]  

  • 8. Interfering with HIV.
    von Bubnoff A
    IAVI Rep; 2006; 10(5):1-5. PubMed ID: 20214237
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of HIV drug resistance mutations: more clues from clinical observations.
    Jenny-Avital ER; Stein DK
    Clin Infect Dis; 2004 May; 38(10):1507-8. PubMed ID: 15156499
    [No Abstract]   [Full Text] [Related]  

  • 10. 25 years of HIV.
    Fauci AS
    Nature; 2008 May; 453(7193):289-90. PubMed ID: 18480799
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomedical methods for HIV prevention: new setbacks.
    Laurence J
    AIDS Read; 2008 Apr; 18(4):163-4. PubMed ID: 18472438
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.
    Peeters M; Toure-Kane C; Nkengasong JN
    AIDS; 2003 Dec; 17(18):2547-60. PubMed ID: 14685049
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
    J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
    [No Abstract]   [Full Text] [Related]  

  • 14. 4th International Workshop on HIV Drug Resistance. Sardinia, Italy, July 6-9, 1995. Abstracts.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 3():S1-46. PubMed ID: 8605585
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospects for a human immunodeficiency virus/AIDS vaccine.
    Murphy FA; Folks TM; Lairmore MD
    Dev Biol Stand; 1990; 72():3-15. PubMed ID: 1704324
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of virus entry: an antiviral mechanism of emerging prominence.
    Koszalka GW; Meanwell NA
    Curr Opin Investig Drugs; 2006 Feb; 7(2):106-8. PubMed ID: 16499279
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.
    De Clercq E
    Biomed Pharmacother; 1996; 50(5):207-15. PubMed ID: 8949401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV. An elusive soluble suppressor.
    Fauci AS
    Nature; 1995 Dec; 378(6557):561. PubMed ID: 8524384
    [No Abstract]   [Full Text] [Related]  

  • 19. Bifunctional properties of analogues of modified nucleotides: immune system cells stimulation and human immunodeficiency virus (HIV) replication inhibition.
    Pisarev VM; Tarussova NB; Leskov VP; Kremlev SG; Kuhanova MK; Tutelyan AV; Otrazheva ED; Pevnitzky LA
    Nucleic Acids Symp Ser; 1991; (24):21. PubMed ID: 1841287
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges in the therapy of HIV infection.
    Yarchoan R; Mitsuya H; Broder S
    Immunol Today; 1993 Jun; 14(6):303-9. PubMed ID: 8397771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.